Back
Solid Biosciences, Inc. Vs. Sarepta Therapeutics, Inc. Industry Stock Comparison
Sell
47
SLDB
Solid Biosciences, Inc.
Last Price:
$5.91
Seasonality Move:
21.2%
Sell
42
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$22.01
Seasonality Move:
10.38%
Sell
47
Solid Biosciences, Inc. (SLDB)
is a Sell
Is Solid Biosciences, Inc. a Buy, Sell or Hold?
-
The current Solid Biosciences, Inc. [SLDB] share price is $5.90. The Score for SLDB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
SLDB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $22.00. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SLDB Stock Price Chart
What is Solid Biosciences, Inc.'s stock price today?
-
The Solid Biosciences, Inc. share price today is $5.90Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SLDB is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $22.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.
SLDB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.43 | Buy |
| Relative Strength Index (14 RSI): | 58.19 | Buy |
| Chaikin Money Flow: | 382484 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.92 - 5.9) | Buy |
| Bollinger Bands (100): | (4.93 - 6.17) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.26 | Buy |
| Relative Strength Index (14 RSI): | 55.88 | Buy |
| Chaikin Money Flow: | 752304 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.76 - 22.42) | Buy |
| Bollinger Bands (100): | (17.71 - 22.25) | Buy |
SLDB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.74 | Buy |
| 20-day SMA: | 5.61 | Buy |
| 50-day SMA: | 5.3 | Buy |
| 200-day SMA: | 4.92 | Buy |
| 8-day EMA: | 4.13 | Buy |
| 20-day EMA: | 2.26 | Buy |
| 50-day EMA: | 1.04 | Buy |
| 200-day EMA: | 0.28 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.39 | Buy |
| 20-day SMA: | 21.39 | Buy |
| 50-day SMA: | 20.77 | Buy |
| 200-day SMA: | 31.26 | Sell |
| 8-day EMA: | 15.23 | Buy |
| 20-day EMA: | 8.35 | Buy |
| 50-day EMA: | 3.84 | Buy |
| 200-day EMA: | 1.03 | Buy |
Solid Biosciences, Inc. Earnings Growth & SLDB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and an increase next year of $0.10 per share.
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.05 per share, and an increase next year of $4.83 per share.
Solid Biosciences, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||